114 related articles for article (PubMed ID: 7683208)
1. The importance of methylthio-IMP for methylmercaptopurine ribonucleoside (Me-MPR) cytotoxicity in Molt F4 human malignant T-lymphoblasts.
Vogt MH; Stet EH; De Abreu RA; Bökkerink JP; Lambooy LH; Trijbels FJ
Biochim Biophys Acta; 1993 Apr; 1181(2):189-94. PubMed ID: 7683208
[TBL] [Abstract][Full Text] [Related]
2. Reversal of 6-mercaptopurine and 6-methylmercaptopurine ribonucleoside cytotoxicity by amidoimidazole carboxamide ribonucleoside in Molt F4 human malignant T-lymphoblasts.
Stet EH; De Abreu RA; Bökkerink JP; Vogels-Mentink TM; Lambooy LH; Trijbels FJ; Trueworthy RC
Biochem Pharmacol; 1993 Aug; 46(3):547-50. PubMed ID: 8347177
[TBL] [Abstract][Full Text] [Related]
3. Decrease in S-adenosylmethionine synthesis by 6-mercaptopurine and methylmercaptopurine ribonucleoside in Molt F4 human malignant lymphoblasts.
Stet EH; De Abreu RA; Bökkerink JP; Blom HJ; Lambooy LH; Vogels-Mentink TM; de Graaf-Hess AC; van Raay-Selten B; Trijbels FJ
Biochem J; 1994 Nov; 304 ( Pt 1)(Pt 1):163-8. PubMed ID: 7998928
[TBL] [Abstract][Full Text] [Related]
4. 6-Mercaptopurine: cytotoxicity and biochemical pharmacology in human malignant T-lymphoblasts.
Bökkerink JP; Stet EH; De Abreu RA; Damen FJ; Hulscher TW; Bakker MA; van Baal JA
Biochem Pharmacol; 1993 Apr; 45(7):1455-63. PubMed ID: 7682415
[TBL] [Abstract][Full Text] [Related]
5. Reversal of methylmercaptopurine ribonucleoside cytotoxicity by purine ribonucleosides and adenine.
Stet EH; De Abreu RA; Bökkerink JP; Lambooy LH; Vogels-Mentink TM; Keizer-Garritsen JJ; Trijbels FJ
Biochem Pharmacol; 1995 Jan; 49(1):49-56. PubMed ID: 7840782
[TBL] [Abstract][Full Text] [Related]
6. Thiopurine induced disturbance of DNA methylation in human malignant cells.
De Abreu R; Lambooy L; Stet E; Vogels-Mentink T; Van den Heuvel L
Adv Enzyme Regul; 1995; 35():251-63. PubMed ID: 7572347
[TBL] [Abstract][Full Text] [Related]
7. On the biochemical modulation of 6-mercaptopurine by methotrexate in murine WEHI-3b leukemia cells in vitro.
Liliemark J; Pettersson B; Peterson C
Leuk Res; 1992; 16(3):275-80. PubMed ID: 1373210
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of IMP dehydrogenase by mycophenolic acid in Molt F4 human malignant lymphoblasts.
Stet EH; De Abreu RA; Bökkerink JP; Lambooy LH; Vogels-Mentink TM; Keizer-Garritsen JJ; Trijbels FJ
Ann Clin Biochem; 1994 Mar; 31 ( Pt 2)():174-80. PubMed ID: 7914720
[TBL] [Abstract][Full Text] [Related]
9. Purine de novo synthesis as the basis of synergism of methotrexate and 6-mercaptopurine in human malignant lymphoblasts of different lineages.
Bökkerink JP; Bakker MA; Hulscher TW; De Abreu RA; Schretlen ED
Biochem Pharmacol; 1988 Jun; 37(12):2321-7. PubMed ID: 2455519
[TBL] [Abstract][Full Text] [Related]
10. Dose-related effects of methotrexate on purine and pyrimidine nucleotides and on cell-kinetic parameters in MOLT-4 malignant human T-lymphoblasts.
Bökkerink JP; De Abreu RA; Bakker MA; Hulscher TW; Van Baal JM; De Vaan GA
Biochem Pharmacol; 1986 Oct; 35(20):3557-64. PubMed ID: 2429668
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of 6- thio- and 6-methylthiopurine ribonucleoside cyclic monophosphates withtheir corresponding nucleosides on the growth of rat hepatoma cells.
Koontz JW; Wicks WD
Cancer Res; 1977 Mar; 37(3):651-7. PubMed ID: 189907
[TBL] [Abstract][Full Text] [Related]
12. Sequence-, time- and dose-dependent synergism of methotrexate and 6-mercaptopurine in malignant human T-lymphoblasts.
Bökkerink JP; Bakker MA; Hulscher TW; De Abreu RR; Schretlen ED; van Laarhoven JP; De Bruyn CH
Biochem Pharmacol; 1986 Oct; 35(20):3549-55. PubMed ID: 2429667
[TBL] [Abstract][Full Text] [Related]
13. A biochemical basis for synergism of 6-mercaptopurine and mycophenolic acid in Molt F4, a human malignant T-lymphoblastic cell line.
Stet EH; De Abreu RA; Janssen YP; Bökkerink JP; Trijbels FJ
Biochim Biophys Acta; 1993 Jan; 1180(3):277-82. PubMed ID: 8422434
[TBL] [Abstract][Full Text] [Related]
14. Effect of de novo purine synthesis inhibitors on 5-fluorouracil metabolism and cytotoxicity.
Cadman E; Benz C; Heimer R; O'Shaughnessy J
Biochem Pharmacol; 1981 Sep; 30(17):2469-72. PubMed ID: 21043247
[TBL] [Abstract][Full Text] [Related]
15. Differing contribution of thiopurine methyltransferase to mercaptopurine versus thioguanine effects in human leukemic cells.
Dervieux T; Blanco JG; Krynetski EY; Vanin EF; Roussel MF; Relling MV
Cancer Res; 2001 Aug; 61(15):5810-6. PubMed ID: 11479220
[TBL] [Abstract][Full Text] [Related]
16. Regulation of de novo purine biosynthesis in human lymphoblasts. Coordinate control of proximal (rate-determining) steps and the inosinic acid branch point.
Hershfield MS; Seegmiller JE
J Biol Chem; 1976 Dec; 251(23):7348-54. PubMed ID: 1002693
[TBL] [Abstract][Full Text] [Related]
17. Biochemical effect of three different inhibitors of purine/pyrimidine metabolism on differentiation in HL60 cells.
Ahmed N; Weidemann MJ
Leuk Res; 1995 Apr; 19(4):263-73. PubMed ID: 7538618
[TBL] [Abstract][Full Text] [Related]
18. Folate-deficient human lymphoblasts: changes in de novo purine and pyrimidine synthesis and phosphoribosylpyrophosphate.
van Der Weyden MB; Rose IS; Newitt P
Eur J Haematol; 1991 Sep; 47(3):213-8. PubMed ID: 1717312
[TBL] [Abstract][Full Text] [Related]
19. Metabolism to methionine and growth stimulation by 5'-methylthioadenosine and 5'-methylthioinosine in mammalian cells.
Carson DA; Willis EH; Kamatani N
Biochem Biophys Res Commun; 1983 Apr; 112(2):391-7. PubMed ID: 6601949
[TBL] [Abstract][Full Text] [Related]
20. Coordinate regulation of the proximal and distal steps of the pathway of purine synthesis de nono in WI-L2 human lymphoblasts.
Hershfield MS; Seegmiller JE
Adv Exp Med Biol; 1977; 76A():19-29. PubMed ID: 855704
[No Abstract] [Full Text] [Related]
[Next] [New Search]
